Fabiflu COVID 19 tablet- Pharmaceutical company Glenmark Pharmaceuticals Antiviral medication for the treatment of patients with mild to moderate COVID-19.
Favipiravir has been introduced under the brand name Fabiflu. Its price is Rs 103 per tablet.
Fabiflu tablet composition
Fabiflu tablet contain Favipiravir 200mg
Fabiflu tablet price
While giving this information on Saturday, Glenmark Pharmaceuticals said that it The drug will be available in 200 mg tablets. Its 34 tablet leaf
The price will be Rs 3,500.
The company said that Fibiflu is favipiravir drug for the treatment of Covid-19. This medicine will be available on doctor's advice at Rs 103 per tablet.
What will be the Fabiflu tablet dosage
On the first day, two doses of 1800 mg have to be taken.
After that, two doses of 800 mg will have to be taken for 14 days
When asked about the manufacturing capacity of this drug, the company said that per
fabiflu covid 19 tablet
fabiflu tablet course
The patient is required to have two minimum of two leaves in the first month itself Fabiflu will be able to provide for 82,500 patients. "On our situation
According to the situation and the company according to the country's healthcare sector Will increase production.
The company uses an active pharmaceutical ingredient (API) for this drug.
Production is taking place at its Ankleshwar plant. Formulation Production Himachal It is being done in Baddi plant of the state.
fabiflu tablet online
No, Fabiflu tablet will not be available online yet. Apart from hospitals, this medicine will also be available through retail channels.
Asked whether the company is supplying hospitals with medicines
We are also considering a tie-up, Glenmark Pharma said,
The priority is the manufacture of Fabiflu so that it can be delivered to patients.
Glenmark definitely on support to the private and government healthcare sector. Will consider Depending on the time and need, he can also consider other appropriate options Will consider.
The Mumbai-based company said on Friday that it would be controlled by the Indian Drug Controller General.
Fabiflu COVID 19 tablet
Company has got permission for the manufacture and marketing of this drug.
Glenmark Pharmaceuticals Chairman and Managing Director Glenn Saldanha said,
"This approval has come at a time when coronavirus cases in India were first
Are growing more rapidly than This makes our healthcare system
Is under a lot of pressure. "
He hoped that with the availability of effective treatment such as fabiflu, this will help reduce the pressure to a great extent.
fabiflu cure covid 19 - fabiflu result
Saldanha said that in clinical trials, Fabiflu reported the coronavirus
Showed significantly better results on patients suffering from mild infections. They said
Other than that it is a food drug which is a convenient treatment
Option. He said that with the company government and the medical community
Will work together so that this drug is easily available to patients across the country
Could.
The company said that its internal research and development team successfully Developed its active pharmaceutical ingredient (API) and formulation Have done.
Fabiflu medicine
Director of Glenmark Pharmaceuticals Indian Formulations, West Asia and Africa Sujesh Vasudevan told an online question and answer session. They strar to chip away at Favipiravir on the grounds that it was called SARS COV2 has been discovered viable on infections. This infection is the Covid-19 pandemic.
fabiflu tablet side effects
The explanation is Glenmark Pharma said that patients with minor diseases who have diabetes or heart problem.
In the event that you are experiencing the illness, they can likewise be given this medication. Saldanha said that it is a medication for food. In such a circumstance when on the emergency clinic structure it will be advantageous.